Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $40.96 in the prior trading day, Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) closed at $40.59, down -0.90%. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 1.58 million shares were traded. CERE stock price reached its highest trading level at $40.95 during the session, while it also had its lowest trading level at $39.91.
Ratios:
Our goal is to gain a better understanding of CERE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.22 and its Current Ratio is at 10.22. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.85.
On September 28, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $33.Piper Sandler initiated its Overweight rating on September 28, 2023, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’24 when COLES N ANTHONY sold 25,000 shares for $41.18 per share. The transaction valued at 1,029,535 led to the insider holds 25,928 shares of the business.
COLES N ANTHONY sold 50,000 shares of CERE for $2,030,520 on Jun 03 ’24. The Director now owns 15,638 shares after completing the transaction at $40.61 per share. On May 10 ’24, another insider, COLES N ANTHONY, who serves as the Director of the company, sold 50,000 shares for $42.10 each. As a result, the insider received 2,105,125 and left with 15,638 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CERE now has a Market Capitalization of 7395295232 and an Enterprise Value of 7031288832.
Stock Price History:
The Beta on a monthly basis for CERE is 1.40, which has changed by 0.34403968 over the last 52 weeks, in comparison to a change of 0.2553556 over the same period for the S&P500. Over the past 52 weeks, CERE has reached a high of $43.59, while it has fallen to a 52-week low of $19.59. The 50-Day Moving Average of the stock is -2.08%, while the 200-Day Moving Average is calculated to be 10.47%.
Shares Statistics:
The stock has traded on average 1.55M shares per day over the past 3-months and 3764030 shares per day over the last 10 days, according to various share statistics. A total of 181.36M shares are outstanding, with a floating share count of 87.51M. Insiders hold about 51.97% of the company’s shares, while institutions hold 47.92% stake in the company. Shares short for CERE as of 1718323200 were 6360119 with a Short Ratio of 4.11, compared to 1715731200 on 7109524. Therefore, it implies a Short% of Shares Outstanding of 6360119 and a Short% of Float of 7.32.
